Trevi Therapeutics
TRVI
#7228
Rank
S$0.50 B
Marketcap
$5.67
Share price
0.48%
Change (1 day)
229.78%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2023 (TTM): -$0.43

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.42. In 2022 the company made an earnings per share (EPS) of -$0.76 an increase over its 2021 EPS that were of -$2.04.

EPS history for Trevi Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.43-43.92%
2022-$0.76-62.67%
2021-$2.04-17.29%
2020-$2.4618.17%
2019-$2.09-46.21%
2018-$3.88